What Will it Take to Make you Look Good, Feel Good, and Think Good at 100? With Peter Diamandis

What Will it Take to Make you Look Good, Feel Good, and Think Good at 100? With Peter Diamandis

Watch the newest video from Big Think

Join Big Think Edge for exclusive videos

----------------------------------------------------------------------------------

Entrepreneur Peter H. Diamandis discusses his work with the new company Human Longevity Inc., which seeks to extend the healthy human lifespan. The goal is to make 100 years old the new 60 with genome sequencing serving as the catalyst for this ambitious achievement. Unlocking the secrets of the human genome should allow us to determine the necessary course of action for achieving longevity.

----------------------------------------------------------------------------------

PETER H. DIAMANDIS:

Peter H. Diamandis is the Chairman and CEO of the X PRIZE Foundation, which leads the world in designing and launching large incentive prizes to drive radical breakthroughs for the benefit of humanity. Best known for the $10 million Ansari X PRIZE for private spaceflight, the Foundation is now launching prizes in Exploration, Life Sciences, Energy, and Education. Diamandis is also the co-Founder & Executive Chairman of the Singularity University, a Silicon Valley based institution teaching graduates and executives about exponentially growing technologies and their potential to address humanity's grand challenges.

Along with fellow Big Think expert Steven Kotler, Diamandis is co-author of the New York Times best selling hardcover book Abundance—The Future Is Better Than You Think which was #2 on the NYTimes List and #1 on Amazon. Their latest book is titled Bold: How to Go Big, Create Wealth and Impact the World.

Diamandis has founded or co-founded many of the leading entrepreneurial companies in this sector including Zero Gravity Corporation, the Rocket Racing League and Space Adventures. He also counsels the world's top enterprises on how to utilize exponential technologies and incentivized innovation to dramatically accelerate their business objectives. Dr. Diamandis attended MIT where he received degrees in molecular genetics and aerospace engineering, as well as Harvard Medical School where he received his M.D. Diamandis' personal motto is: "The best way to predict the future is to create it yourself!"

----------------------------------------------------------------------------------

TRANSCRIPT:

Peter Diamandis: In 2014 I announced one of my boldest companies. It’s a company called Human Longevity Inc. I co-founded it with Craig Venter, the first guy to sequence the human genome. And Bob Hariri, one of the top stem cell scientists and businessmen in the world. And we founded Human Longevity Incorporated as a means to extend the healthy human lifespan. To make 100 years old the new 60. And in the first year of operations we built the largest genome-sequencing facility in the world. And that genome-sequencing facility besides your genome, the 3.2 billion letters from your father and the 3.2 billion letters from your mother, we are also sequencing your microbiome. You are a collection of 10 trillion human cells and 100 trillion bacterial cells. But besides that your full phenotype, your MRI, the full imaging of your body, your metabolome, the 24 chemicals in your bloodstream — all of this data is being collected and then we’re using machine learning to mine that data for the secrets of what drives cancer, what drives heart disease, what drives neurodegenerative disease.

With a mission of making sure that when you’re 100, you look good, you move good, you think good, you feel great. And I think that’s where we’re going. Our ability to rapidly sequence a genome — take what was 100 million dollars and nine months down to a thousand bucks and a few hours is going to unlock the secrets. We are the product of our genome. How you look, how you sound, the structures of your brain are all coded for in our genes. So as we unlock this we’re going to create tremendous breakthroughs in the healthy human lifespan, inventing new drugs that are personalized to you. It’s going to reinvent health on an epic scale.

Entrepreneur Peter H. Diamandis discusses his work with the new company Human Longevity Inc., which seeks to extend the healthy human lifespan. The goal is to make 100 years old the new 60 with genome sequencing serving as the catalyst for this ambitious achievement. Unlocking the secrets of the human genome should allow us to determine the necessary course of action for achieving longevity.